Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 562 Specimen Handling 489 Carboplatin 451 Magnetic Resonance Spectroscopy 443 Cyclophosphamide 418 Cisplatin 408 Radiotherapy 354 Gemcitabine 316 Bevacizumab 313 Paclitaxel 300 Biopsy 290 Drug Therapy 285 Blood Specimen Collection 248 Capecitabine 245 Oxaliplatin 242 fludarabine 239 Nivolumab 236 venetoclax 221 Injections 213 Docetaxel 209 Fluorouracil 205 Dexamethasone 187 Radiosurgery 184 Rituximab 161 Standard of Care 158 Pemetrexed 156 Surgical Procedures, Operative 148 durvalumab 146 atezolizumab 144 Leucovorin 138

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lysine × Clear all

NCT07150806 2026-05-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Ohio State University Comprehensive Cancer Center

Phase 1/2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡